You are here

News

A conversation on the past, present and what the future holds for battling disease.With billions of dollars being spent in research and development each year, with thousands of grassroots and... Read more
The U.S. Food and Drug Administration today approved Harvoni (ledipasvir and sofosbuvir) to treat chronic hepatitis C virus (HCV) genotype 1 infection.Harvoni is the first combination pill approved... Read more
Advances in understanding the molecular basis of cancer have led to an escalation in comprehensive panels of multi-marker gene assays of cancer-driver mutations, as opposed to traditional single-... Read more
Friends of Cancer Research and Alexandria Real Estate Equities, Inc./Alexandria Venture InvestmentsHost Forum on Next Generation SequencingA Blueprint For Drug/Diagnostic Co-development    Washington... Read more
LUNGevity Foundation announces Friends of Cancer Research Chairperson and Founder Ellen Sigal, PhD, and Executive Director Jeff Allen, PhD, as the September LUNGevity Heroes for the work they have... Read more
Aspen Institute Launches New Partnershipwith Friends of Cancer ResearchCollaboration to feature policy briefings on “Cancer Research in the 21st Century”;speakers for inaugural event include Dr.... Read more
21st Century Cures Initiative – House Energy and Commerce Committee’s FDA, healthcare reform initiative – gets praise for its all-encompassing assessment of biomedical innovation process, but... Read more
ON Aug. 6, researchers announced in The New England Journal of Medicine that they had found that mutations in a gene called PALB2 greatly increase the risk of breast cancer. This is one of the... Read more
Scott Gottlieb, M.D., American Enterprise Institute, and Jeff Allen, Friends of Cancer Research executive director, discuss the FDA's drug approval process and the need in some cases to allow access... Read more
Groundbreaking study in squamous cell lung cancer opens at more than a hundred and fifty new locationsThe Lung-MAP trial, a multi-drug, multi-sub-study, biomarker-driven clinical trial for patients... Read more

Pages